Top compounds associated with response to SBDS


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.24 2e-11
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.24 4e-11
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.21 3e-10
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.21 3e-10
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.19 4e-09
mRNA CD-437 CTRPv2 pan-cancer AAC -0.21 4e-09
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.21 1e-08
mRNA barasertib CTRPv2 pan-cancer AAC -0.2 1e-08
mRNA clofarabine CTRPv2 pan-cancer AAC -0.18 2e-08
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 2e-08
Download CSV